Abstract

Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds

Author(s): Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok

Issue: Jan/Feb 2006 - Sports Medicine

Page(s): 74-78

Download in electronic PDF format for $75
  • Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 1
  • Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 2
  • Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 3
  • Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 4
  • Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Page 5

Abstract

The objective of this study was to evaluate the stability of two phenytoin sodium suspensions in 0.9% sodium chloride solution for use in noninstitutional settings (where pharmacies are not present) to dispense phenytoin on a daily basis. A generic extended phenytoin sodium (Mylan) and a name brand phenytoin sodium (Dilantin) in suspension form were evaluated. Both suspensions were first assessed for degradation during frozen storage at designated time intervals. Frozen samples were compared with freshly prepared samples. The chemical stability of phenytoin concentrations in the samples was assessed by using a high-performance liquid chromatography analytical technique. During the course of the experiment, the samples showed no crystallization and the pH remained in a range of 10.6 to 10.73. The suspensions were tested for contamination. The results show that Dilantin and Mylan suspensions remained stable and free of contamination. Suspensions of phenytoin sodium in 0.9% sodium chloride solution are stable at room temperature for at least 2 weeks.

Related Keywords

  • phenytoin sodium
  • suspensions
  • topical preparation
  • wound healing
  • stability
  • pressure ulcers
  • decubitus ulcers

Related Categories

  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • WOUND CARE
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jan/Feb 2006
Pg. 74-78
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Author(s): Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
Mar/Apr 2002
Pg. 92-95
Options in Wound Care
Author(s): Kincaid Michele R
Jul/Aug 2020
Pg. 278-281
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Author(s): Riepl Mike
Jul/Aug 2004
Pg. 265-267
Case Report: Wound Care of a Diabetic Foot Ulcer
Author(s): Wynn Tom
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
May/Jun 2020
Pg. 182-186
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Author(s): Riepl Mike
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Jul/Aug 2007
Pg. 333
Phenytoin Sodium 20-mg/mL Topical Suspension
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 196-213
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Author(s): Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
Jul/Aug 2000
Pg. 301
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 282-285
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Author(s): Riepl Mike
Jan/Feb 2009
Pg. 25-29
Compounding with Sucralfate for the Treatment of External Wounds
Author(s): Wynn Tom, Williams LaVonn A
Jan/Feb 2017
Pg. 22-27
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
May/Jun 2003
Pg. 176-178
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Author(s): Israel Alan
Sep/Oct 2021
Pg. 372-377
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Author(s): Riepl Mike
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Nov/Dec 2020
Pg. 501-508
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Sep/Oct 2004
Pg. 354-357
Current Topical Treatments in Wound Healing - Part 2
Author(s): Helmke Christopher D